Status:
UNKNOWN
Pathogenesis of Intestinal Behcet's Syndrome
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Behcet's Syndrome, Intestinal Type
Eligibility:
All Genders
20-65 years
Brief Summary
There is a direct interaction between food, intestinal flora and the intestinal barrier composed of intestinal epithelial cells and mucosal immunity, whose composition and functional alterations are t...
Eligibility Criteria
Inclusion
- Behcet's syndrome patients with intestinal involvement:
- Attendance at Peking Union Medical College Hospital, fulfillment of one of the two diagnostic criteria for BS (1990 Criteria of International Study Group for Behcet's disease or 2014 International Criteria for Behçet's Disease), and well-documented medical records;
- Age 20-65 years old;
- Have evidence of GI involvement, including clinical manifestations, laboratory tests, endoscopy, imaging and pathology;
- Signed written informed consent and willingness to cooperate.
- Behcet's syndrome patients with intestinal involvement:
- Attendance at Peking Union Medical College Hospital, fulfillment of one of the two diagnostic criteria for BS (1990 Criteria of International Study Group for Behcet's disease or 2014 International Criteria for Behçet's Disease), and well-documented medical records;
- Age 20-65 years old;
- Have no evidence of GI involvement, including clinical manifestations, laboratory tests, endoscopy, imaging and pathology;
- Signed written informed consent and willingness to cooperate.
- Inflammatory bowel disease patients:
- Attended Peking Union Medical College Hospital and was diagnosed with Crohn's disease by a combination of clinical, imaging, and pathologic diagnosis;
- Age 20-65 years old;
- Signed written informed consent and willingness to cooperate.
- Health controls:
- Healthy individuals aged 20-65 years;
- Signed written informed consent and willingness to cooperate.
Exclusion
- Other systemic diseases, such as autoimmune diseases, infectious diseases, malignant tumors, etc;
- Patients with other intestinal diseases, such as intestinal tumors, intestinal tuberculosis, intestinal infections;
- Patients with other oral diseases, such as cavity caries, oral abscesses, oral tumors, oral candidiasis, and dry mouth;
- Patients taking antibiotics and probiotics within one month.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06026020
Start Date
September 1 2023
End Date
December 1 2025
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730